A Study Comparing Dopamine D3 and D2 Receptor Occupancies in Healthy Subjects Treated with a Single Dose of Blonanserin Using a Positron Emission Tomography with [11C]-(+)-PHNO

Trial Profile

A Study Comparing Dopamine D3 and D2 Receptor Occupancies in Healthy Subjects Treated with a Single Dose of Blonanserin Using a Positron Emission Tomography with [11C]-(+)-PHNO

Completed
Phase of Trial: Phase I

Latest Information Update: 23 Jan 2018

At a glance

  • Drugs Blonanserin (Primary)
  • Indications Schizophrenia
  • Focus Pharmacodynamics
  • Most Recent Events

    • 23 Jan 2018 New trial record
    • 13 Jan 2018 Results published in the International Journal of Neuropsychopharmacology.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top